Study unveils novel treatment for blocking SARS-CoV-2 entry into cells

In light of the ongoing threat posed by new viruses following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which led to the COVID-19 pandemic, new antiviral drugs continue to be developed to effectively block viral entry into the human body.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup